Denali Therapeutics Cash from Financing (TTM) Trends

Denali Therapeutics Inc (DNLI)

15.45 +0.49 (+3.28%) USD | NASDAQ | Apr 26, 14:03

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	17.82M
September 30, 2023	312.77M
June 30, 2023	315.43M
March 31, 2023	310.81M
December 31, 2022	310.67M
September 30, 2022	16.19M
June 30, 2022	14.35M
March 31, 2022	16.99M
December 31, 2021	19.35M
September 30, 2021	23.70M
June 30, 2021	446.29M
March 31, 2021	442.66M
December 31, 2020	634.75M

Date	Value
September 30, 2020	627.26M
June 30, 2020	202.04M
March 31, 2020	201.20M
December 31, 2019	6.19M
September 30, 2019	5.846M
June 30, 2019	5.825M
March 31, 2019	4.688M
December 31, 2018	97.02M
September 30, 2018	390.92M
June 30, 2018	390.62M
March 31, 2018	389.24M
December 31, 2017	296.32M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

5.825M

Minimum

Jun 2019

634.75M

Maximum

Dec 2020

206.85M

Average

201.20M

Median

Mar 2020

Cash from Financing (TTM) Benchmarks